aHÜS Kayıt Sistemi
Literatürler
- Thrombotic Thrombocytopenic Purpura and the Atypical Hemolytic Uremic Syndrome
- Terminal complement inhibitor eculizumab in atypical hemolytic-uremic syndrome
- Atypical HUS: time to take stock of current guidelines and outcome measures?
- Complement disorders and hemolytic uremic syndrome
- Treatment of atypical hemolytic uremic syndrome and thrombotic microangiopathies: a focus on eculizumab.
- Use of eculizumab for atypical haemolytic uraemic syndrome and C3 glomerulopathies
- Atypical hemolytic uremic syndrome: what is it, how is it diagnosed, and how is it treated?